💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Masimo Corporation (MASI)
« Back to company indexMASI Chatter Timeline
Stock Ticker for MASI
Most Active Tweeters for MASI
| User | Tweets |
|---|---|
| @Beeken_health | 20 |
| @TShortalgo | 10 |
| @Slayer10Stock | 4 |
| @insidertra | 2 |
| @StockNewsBot2 | 2 |
Recent Tweets for MASI
 |
@joshua_t_white Perhaps the most egregious or "Draconian" example is Masimo $MASI a medical device firm whose founder is CEO and Chair of the board. (12/N) March 21st 2023, 1:03pm |
 |
@Slayer10Stock $MASI Awaiting Buy Signal based off 5 signals $822 net profit 6.14 profit factor 80% win rate on a 15-min chart. Fr… https://t.co/PxyInnluCw March 21st 2023, 11:03am |
 |
@TShortalgo $MASI Trading Ideas | Awaiting Short signal. 90.91% Profitability based on 13 trades. Profit factor is 57.21. Learn… https://t.co/SjTnMh6kaS March 21st 2023, 10:03am |
 |
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/8du83omrif March 20th 2023, 2:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/Js6ERkQjI0 March 19th 2023, 8:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/U6C0Vh7cZj March 19th 2023, 8:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/PSv9pbSXXo March 19th 2023, 8:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/hOUMJDnOiI March 19th 2023, 8:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/D5KEIwzpc5 March 19th 2023, 7:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/tUneR1bgg7 March 19th 2023, 7:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/gMHQ098duH March 19th 2023, 6:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/msNPBjodJm March 19th 2023, 6:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/fLxeITfe6F March 19th 2023, 6:03am |
|
@TShortalgo $MASI Trading Ideas | Awaiting Buy signal. 88.89% Profitability based on 9 trades. Profit factor is 177.34. Learn m… https://t.co/IkoU5PwOgF March 19th 2023, 5:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/8Npd9iFbwP March 19th 2023, 5:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/iEWdGPrqR2 March 19th 2023, 3:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/PP78vjdglG March 19th 2023, 2:03am |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/YoJSOOZqgF March 18th 2023, 6:03pm |
 |
@stockresearchhq Masimo Corporation $MASI quarterly revenue growth rate YoY of 78.70% ranked ????? in our db. Impressive! https://t.co/qTsAwt2LBz March 18th 2023, 4:03pm |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/VlGca54Gtw March 18th 2023, 4:03pm |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/SiPuP3gLtL March 18th 2023, 3:03pm |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/jGP6j72hYj March 18th 2023, 3:03pm |
|
@Beeken_health $MASI - Masimo Corporation: Re-Rating Nearing Completion https://t.co/XJqlRPTLhK March 18th 2023, 3:03pm |
|
@TShortalgo $MASI Trading Ideas | Awaiting Buy signal. 88.89% Profitability based on 9 trades. Profit factor is 177.34. Learn m… https://t.co/qXKyCFRV8j March 18th 2023, 6:03am |
|
@Beeken_health $MASI - Masimo (MASI) Moves to Strong Buy: Rationale Behind the Upgrade https://t.co/Qy3FppFC9D March 17th 2023, 10:03pm |
|
@Beeken_health $MASI - Masimo (MASI) Moves to Strong Buy: Rationale Behind the Upgrade https://t.co/8V2OZrLpXU March 17th 2023, 10:03pm |
|
@TShortalgo $MASI Trading Ideas | Awaiting Short signal. 80% Profitability based on 18 trades. Profit factor is 6.82. Learn mor… https://t.co/ZgwyXjkY3f March 17th 2023, 8:03am |
|
@Slayer10Stock $MASI Awaiting Buy Signal based off 9 signals $1,184 net profit 3.50 profit factor 77% win rate on a 15-min chart.… https://t.co/eUnuk9rroP March 16th 2023, 2:03pm |
 |
@StockAutomate $MASI Chart analysis points towards a downward stock trajectory. We alerted the SELL signal at $176.39 and we were… https://t.co/xp3TVRy7bJ March 16th 2023, 3:03am |
 |
@stockmktgenius $MASI Masimo Corporation - Comm Top stock up 65% from low. Close: 178.88 VolvsAvg: 0.74 Liq: $48M https://t.co/Yadav5Hoor March 15th 2023, 7:03pm |
 |
@FlashAlert_me $MASI [15s. delayed]: Issued Press Release on March 15, 06:18:00: Samenvatting: Europese Vereniging voor Anesthesio… https://t.co/mNhMBQSjNW March 15th 2023, 10:03am |
 |
@algobotnews Masimo announce updated ESAIC guidelines recommend hemoglobin monitoring $MASI March 15th 2023, 9:03am |
 |
@otcdynamics $MASI European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin… https://t.co/PRQX8Z3mM5 March 15th 2023, 7:03am |
|
@otcdynamics $MASI European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin… https://t.co/HFRSeKnqQu March 15th 2023, 7:03am |
|
@TShortalgo $MASI Trading Ideas | Awaiting Short signal. 100% Profitability based on 13 trades. Profit factor is 100. Learn mor… https://t.co/08HaqYgtSd March 15th 2023, 7:03am |
 |
@StockNewsBot2 $MASI European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin… https://t.co/nWU3OQ4ffT March 15th 2023, 7:03am |
 |
@stock_titan $MASI European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin… https://t.co/hyAyq2Gj1b March 15th 2023, 7:03am |
 |
@WebChronicleTo1 $MASI European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin… https://t.co/K3bZiGT9KL March 15th 2023, 7:03am |
|
@TShortalgo $MASI Trading Ideas | Awaiting Short signal. 90% Profitability based on 13 trades. Profit factor is 9.3. Learn more… https://t.co/eBDfNUz2M7 March 14th 2023, 12:03pm |
|
@TShortalgo $MASI Trading Ideas | Awaiting Short signal. 90% Profitability based on 13 trades. Profit factor is 9.46. Learn mor… https://t.co/loXmlHAJyi March 13th 2023, 7:03pm |
|
@Slayer10Stock $MASI Awaiting Buy Signal based off 6 signals $921 net profit 9.70 profit factor 83% win rate on a 15-min chart. Fr… https://t.co/mTDkaoEfeg March 13th 2023, 2:03pm |
 |
@ChartMill $MASI was analyzed by 14 analysts. The buy consensus is at 86%. So analysts seem to be very confident about $MASI.… https://t.co/fYIFNOKAAK March 13th 2023, 1:03pm |
|
@FlashAlert_me $MASI [15s. delayed] filed form SC 13D/A on March 13, 06:32:06 https://t.co/xem7xTAvDW March 13th 2023, 10:03am |
|
@TShortalgo $MASI Trading Ideas | Awaiting Buy signal. 88.89% Profitability based on 12 trades. Profit factor is 8.04. Learn mo… https://t.co/xUrKowmHS7 March 12th 2023, 2:03am |
|
@TShortalgo $MASI Trading Ideas | Awaiting Buy signal. 71.43% Profitability based on 16 trades. Profit factor is 4.96. Learn mo… https://t.co/TwLi6nflV4 March 9th 2023, 8:03am |
 |
@bthefirsttoknow First out// $MASI: Study Finds That Masimo PVi Capable Of Predicting Fluid Responsiveness in Young Children Undergoing March 9th 2023, 7:03am |
|
@StockNewsBot2 $MASI New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosu… https://t.co/8mBb5cchhJ March 9th 2023, 7:03am |
|
@stock_titan $MASI New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosu… https://t.co/8fsoXLNNfy March 9th 2023, 7:03am |
|
@WebChronicleTo1 $MASI New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosu… https://t.co/dRM8fG2ZVv March 9th 2023, 7:03am |
 |
@CashFlow_Fool Added to $MASI (0.2%): building out a position https://t.co/Q7WfCcpArd March 8th 2023, 7:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.